Email: cspc@cspc.cn
Media
News Center
Jul. 17
2023
CSPC Ranked Fourth in China's Top 100 Chemical Pharmaceutical Enterprises
Jul. 11
VOLUNTARY ANNOUNCEMENT - DESVENLAFAXINE SUCCINATE EXTENDED-RELEASE TABLETS OBTAINS DRUG REGISTRATION APPROVAL
VOLUNTARY ANNOUNCEMENT - RABEPRAZOLE SODIUM ENTERIC-COATED TABLETS OBTAINS DRUG REGISTRATION APPROVAL
Jun. 28
Research Results of JMT101 of CSPC Published in Subjournal of Nature
CSPC Attending Beijing-Tianjin-Hebei Pharmaceutical Innovation and Development Conference
Jun. 27
VOLUNTARY ANNOUNCEMENT - CHINA'S FIRST ANTI-GFRAL MONOCLONAL ANTIBODY JMT203 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
